연구
연구업적
최근 5년 연구업적 현황
| 연도 | 2025년 | 2024년 | 2023년 | 2022년 | 2021년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 196편 | 179편 | 173편 | 163편 | 184편 |
| 공동 | 132편 | 147편 | 120편 | 115편 | 136편 | |
| 합계 | 328편 | 326편 | 293편 | 278편 | 320편 | |
2305. High tumoral PD-L1 expression and low PD-1+ or CD8+ tumor-infiltrating lymphocytes are predictive of a poor prognosis in primary diffuse large B-cell lymphoma of the central nervous system.
Sehui Kim, Soo Jeong Nam, Changhee Park, Dohee Kwon, Jeemin Yim, Seung Geun Song, Chan-Young Ock, Young A Kim, Sung Hye Park, Tae Min Kim, Yoon Kyung Jeon
OncoImmunology 2019;8(9):e1626653
Link
2304. Identification of microRNAs modulated by DNA hypomethylating drugs in extranodal NK/T-cell lymphoma.
Heounjeong Goa,b,c , Ji-Young Jangb,d, Chul-Woo Kima,b,d, Jooryung Huhc, Pil-Jong Kime and
Yoon Kyung Jeona,b
Leukemia & Lymphoma 2019 Aug 23:1-9
Link
2303. MET Receptor Tyrosine Kinase Regulates the Expression of Co-Stimulatory and Co-Inhibitory Molecules in Tumor Cells and Contributes to PD-L1-Mediated Suppression of Immune Cell Function
Hyun Kyung Ahn, Sehui Kim, Dohee Kwon, Jaemoon Koh, Young A Kim, Kwangsoo Kim, Doo Hyun Chung, Yoon Kyung Jeon
International Journal of Molecular Sciences 2019;20(17). Pii: E4287
Link
2302. Programmed cell death ligand-1-mediated enhancement of hexokinase 2 expression is inversely related to T-cell effector gene expression in non-small-cell lung cancer
Sehui Kim, Ji-Young Jang, Jaemoon Koh, Dohee Kwon, Young A Kim, Jin Chul Paeng,
Chan-Young Ock, Bhumsuk Keam, Miso Kim, Tae Min Kim, Dae Seog Heo, Doo Hyun Chung, Yoon Kyung Jeon
Journal of Experimental & Clinical Cancer Research 2019;38(1):462
Link
2301. Proposal of the Minimal Number of Retrieved Regional Lymph Nodes for Accurate Staging of Distal Bile Duct Cancer and Clinical Validation of the Three-tier Lymph Node Staging System (AJCC 8th edition).
Kang JS, Higuchi R, He J, Yamamoto M, Wolfgang CL, Cameron JL, Han Y, Son D,
Lee S, Choi YJ, Byun Y, Kim H, Kwon W, Kim SW, Park T, Jang JY.
J Hepatobiliary Pancreat Sci. 2019 Oct 21.
Link
2300. Effects of Pancreatic Enzyme Replacement Therapy on Body Weight and Nutritional Assessments After Pancreatoduodenectomy in a Randomized Trial.
Kim H, Yoon YS, Han Y, Kwon W, Kim SW, Han HS, Yoon DS, Park JS, Park SJ, Han
SS, Lee SE, Choi SH, Han IW, Kim E, Jang JY.
Clin Gastroenterol Hepatol. 2019 Sep 11.
Link
2299. Malignant conversion and peritoneal dissemination after endoscopic ultrasound-guided ethanol ablation in intraductal papillary mucinous neoplasm of the pancreas.
Jang JY, Byun Y, Han Y, Kim H, Kwon W.
J Hepatobiliary Pancreat Sci. 2019
Oct;26(10):467-472.
Link
2298. Clinical validation of scoring systems of postoperative pancreatic fistula after pancreatoduodenectomy: applicability to Eastern cohorts?
Kang JS, Park T, Han Y, Lee S, Kim JR, Kim H, Kwon W, Kim SW, Heo JS, Choi SH,
Choi DW, Kim SC, Hong TH, Yoon DS, Park JS, Park SJ, Han SS, Choi SB, Kim JS, Lim
CS, Jang JY.
Hepatobiliary Surg Nutr. 2019 Jun;8(3):211-218.
Link
2297. Recurrence patterns after pancreaticoduodenectomy for ampullary cancer.
Kim H, Kwon W, Kim JR, Byun Y, Jang JY, Kim SW.
J Hepatobiliary Pancreat Sci. 2019
May;26(5):179-186.
Link
2296. The Implication of Cytogenetic Alterations in Pancreatic Ductal Adenocarcinoma and Intraductal Papillary Mucinous Neoplasm Identified by Fluorescence In Situ Hybridization and Their Potential Diagnostic Utility.
Lim CS, Im K, Lee DS, Kwon W, Kim JR, Han Y, Kim SW, Jang JY.
Gut Liver. 2019 Sep 20.
Link